LYFE Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Nucleixnucleix.comin𝕏Apr 2021 · $55M
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.
BiotechDigital HealthHealthtechMedical Devices
Eli Frydman(President EMEA)
Co-investorsGefen CapitalOrbiMedRA CapitalBlackRockLilly Asia VenturesSands Capital Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.